Evidence map›Paper›PMID 29436331›Full record

ArticleThe British journal of psychiatry : the journal of mental science2018

Impact of adherence to antidepressants on long-term prescription opioid use cessation.

Jeffrey F Scherrer, Joanne Salas, Mark D Sullivan, Brian K Ahmedani, Laurel A Copeland, Kathleen K Bucholz, Thomas Burroughs, F David Schneider, Patrick J Lustman

Abstract read
In one paragraph

Article in The British journal of psychiatry : the journal of mental science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Observational evidence linking psychotropic medicines to the dispensing of opioid agents in later life.Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society · 2024
    Observational
  7. Article
  8. Article
  9. The Prescription Opioids and Depression Pathways Cohort Study.Journal of psychiatry and brain science · 2020
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jeffrey F ScherrerDepartment of Family and Community Medicine,Saint Louis University School of Medicine,St. Louis,MissouriandHarry S. Truman Veterans Administration Medical Center,Columbia,Missouri.
Joanne SalasDepartment of Family and Community Medicine,Saint Louis University School of Medicine,St. Louis,MissouriandHarry S. Truman Veterans Administration Medical Center,Columbia,Missouri.
Mark D SullivanDepartment of Psychiatry and Behavioral Health,University of Washington School of Medicine,Seattle,Washington.
Brian K AhmedaniHenry Ford Health System,Center for Health Policy and Health Services Research,Detroit,Michigan.
Laurel A CopelandVA Central Western Massachusetts Healthcare System,Leeds,Massachusetts,Center for Applied Health Research,Baylor Scott & White Health,Temple,Texas and UT Health San Antonio,San Antonio,Texas.
Kathleen K BucholzDepartment of Psychiatry,Washington University School of Medicine,St. Louis,Missouri.
Thomas BurroughsSaint Louis University Center for Outcomes Research,St. Louis,Missouri.
F David SchneiderDepartment of Family and Community Medicine,Saint Louis University School of Medicine,St. Louis,Missouri.
Patrick J LustmanThe Bell Street Clinic, VA St. Louis Health Care System - John Cochran Division,St. LouisandDepartment of Psychiatry,Washington University School of Medicine,St. Louis,Missouri,USA.

Funding

Prescription Opioid Analgesics and Risk of Major DepressionR21MH101389 · NIMH · SAINT LOUIS UNIVERSITY · PI SCHERRER, JEFFREY F. · 2014 to 2015
$392k
NIMH NIH HHS R21 MH101389
6 · The paper itself

Abstract

backgroundDepression contributes to persistent opioid analgesic use (OAU). Treating depression may increase opioid cessation. Aims To determine if adherence to antidepressant medications (ADMs) v. non-adherence was associated with opioid cessation in patients with a new depression episode after >90 days of OAU.

methodPatients with non-cancer, non-HIV pain (n = 2821), with a new episode of depression following >90 days of OAU, were eligible if they received ≥1 ADM prescription from 2002 to 2012. ADM adherence was defined as >80% of days covered. Opioid cessation was defined as ≥182 days without a prescription refill. Confounding was controlled by inverse probability of treatment weighting.

resultsIn weighted data, the incidence rate of opioid cessation was significantly (P = 0.007) greater in patients who adhered v. did not adhered to taking antidepressants (57.2/1000 v. 45.0/1000 person-years). ADM adherence was significantly associated with opioid cessation (odds ratio (OR) = 1.24, 95% CI 1.05-1.46).

conclusionsADM adherence, compared with non-adherence, is associated with opioid cessation in non-cancer pain. Opioid taper and cessation may be more successful when depression is treated to remission. Declaration of interest None.

Indexed as

Drug MonitoringAdolescentAdultAgedAged, 80 and overAnalgesics, OpioidAntidepressive AgentsComorbidityDepressive DisorderFemaleHumansMaleMiddle AgedPainRetrospective StudiesYoung AdultAnalgesics, OpioidAntidepressive Agents

Identifiers

PMID29436331
PMCPMC6655534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.